Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
J Clin Oncol. Author manuscript; available in PMC 2006 August 17.
Published in final edited form as:
PMCID: PMC1550285

Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer



Cancer survivors are at increased risk for several comorbid conditions, and many seek lifestyle change to reduce dysfunction and improve long-term health. To better understand the impact of cancer on adult survivors' health and health behaviors, a review was conducted to determine (1) prevalent physical health conditions, (2) persistent lifestyle changes, and (3) outcomes of previous lifestyle interventions aimed at improving health within this population.


Relevant studies from 1966 and beyond were identified through MEDLINE and PubMed searches.


Cancer survivors are at increased risk for progressive disease but also for second primaries, osteoporosis, obesity, cardiovascular disease, diabetes, and functional decline. To improve overall health, survivors frequently initiate diet, exercise, and other lifestyle changes after diagnosis. However, those who are male, older, and less educated are less likely to adopt these changes. There also is selective uptake of messages, as evidenced by findings that only 25% to 42% of survivors consume adequate amounts of fruits and vegetables, and approximately 70% of breast and prostate cancer survivors are overweight or obese. Several behavioral interventions show promise for improving survivors' health-related outcomes. Oncologists can play a pivotal role in health promotion, yet only 20% provide such guidance.


With 64% of cancer patients surviving > 5 years beyond diagnosis, oncologists are challenged to expand their focus from acute care to managing the long-term health consequences of cancer. Although more research is needed, opportunities exist for oncologists to promote lifestyle changes that may improve the length and quality of life of their patients.


Cancer survival has risen steadily over the past three decades for all cancers combined. Prevalence proportions estimated from cancer incidence and follow-up data from the Surveillance, Epidemiology, and End Results registry indicate that there currently are 9.8 million cancer survivors in the United States alone, representing between 3% and 4% of the entire US population.1-4 As advances in cancer detection, treatment, and care diffuse into clinical practice, the number of survivors is expected to increase. The aging of the population and a longer life expectancy in general will contribute further to this trend.

The proportion of long-term cancer survivors also continues to grow. Today, in the absence of other competing causes of death, an estimated 64% of those diagnosed with cancer can expect to be alive in 5 years, whereas in 1971 long-term survival was estimated at < 50%.4 As the number of survivors and their length of survival expand, long-term health issues specific to cancer survival are fast emerging as a public health concern. The purpose of this review is to (1) describe common medical sequelae occurring among adult cancer survivors, (2) summarize lifestyle changes that are pursued by this population after diagnosis, and (3) examine lifestyle interventions that may hold promise in reducing adverse treatment-related effects and comorbidity. Relevant observation and intervention studies were identified through MEDLINE and PubMed searches using the specific search term “cancer survivor,” as well as cross-referenced medical subject heading terms “neoplasms,” “survivors,” “diet,” “exercise,” “physical activity,” “smoking,” “intervention,” and “lifestyle.” Although all articles from 1966 and beyond were considered, for the sake of brevity the search was limited to articles in the English language that describe physical health outcomes and not inclusive of alternative or complementary medicine. Additionally, we incorporated summaries of recent reviews when they were available. Data suggest that although the cancer survivor is at risk for a host of conditions that range from cardiac compromise to secondary cancers, the oncologist may be optimally positioned to capitalize on the “teachable moment” created by the cancer diagnosis and play a pivotal role in guiding survivors toward behaviors that improve overall health and physical well-being.5-8


Cancer survivors are high healthcare utilizers who have several distinct healthcare issues.9 Data clearly show that cancer survivors are at greater risk for developing secondary cancers and other diseases; these risks may be brought on by cancer treatment, genetic predisposition, and/or common lifestyle factors.2,10-13 Although the threat of progressive or recurrent disease is at the forefront of health concerns for a cancer survivor, a comparison by Brown et al10 of > 1.2 million patient records obtained from the Surveillance, Epidemiology, and End Results database with those obtained from the National Center for Health Statistics shows that “the evidence that cancer patients die of noncancer causes at a higher rate than persons in the general population is overwhelming.” Increased morbidity and decreased functional status and disability that result from cancer, its treatment, or health-related sequelae also are significant concerns.


Second cancers account for a large number of new cancers.1,2,11,13 A second primary may result from host susceptibility (genetic predisposition or immunodeficiency), a clustering of risk factors, common carcinogenic influences, treatment for the first tumor (eg, breast cancer after treatment for Hodgkin's disease), diagnostic surveillance, a chance event, or the interaction of these factors.1,2,13 Second cancers may occur in the same organ site (eg, breast or colorectal) and also at other sites, with leukemia and solid tumors of the breast, bone, thyroid, and bladder being reported most frequently. Thus, survivors can benefit from guidelines established for the primary prevention of these secondary cancers, as well as continued surveillance.1,14,15


Obesity is a well-established risk factor for cancers of the breast (postmenopausal), colon, kidney (renal cell), esophagus (adenocarcinoma), and endometrium; thus, a large proportion of cancer patients are overweight or obese at the time of diagnosis.16,17 Additional weight gain also can occur during or after active cancer treatment, an occurrence that has been documented frequently among individuals with breast cancer but recently was reported among testicular and gastrointestinal cancer patients, as well.15,18,19 Given data that obesity is associated with cancer recurrence in both breast and prostate cancer and reduced quality of life (QOL) among survivors, there is compelling evidence to support weight-control efforts in this population.14,15,18-20 Also, gradual weight loss has proven benefits in controlling hypertension, hyperinsulinemia, pain, dyslipidemia, and improving levels of physical functioning—conditions that reportedly are significant problems in the survivor population.14,15,21 Accordingly, the American Cancer Society Recommendations for Cancer Survivors list the “achievement of a healthy weight” as a primary goal.14

Obesity represents one of several metabolic disorders that are frequently manifest among cancer survivors—disorders that are grouped under the umbrella of “the metabolic syndrome” and include diabetes and cardiovascular disease (CVD).14,19,21 Insulin resistance is the underlying event associated with the metabolic syndrome, and insulin resistance, co-occurring hyperinsulinemia, and/or diabetes have been reported as health concerns among cancer survivors.10,22-24 As Brown et al10 observed, diabetes may play a significant role in the increased number of non–cancer-related deaths among survivors; however, its role in progressive cancer is still speculative.16

Although there is one study that suggests that older breast cancer patients derive a cardioprotective benefit from their diagnosis and/or associated treatments (most likely tamoxifen),25 most reports indicate that CVD is a major health issue among survivors, as evidenced by mortality data that show that half of non–cancer-related deaths are attributed to CVD.10 Risk is especially high among men with prostate cancer who receive hormone-ablation therapy, patients who receive adriamycin, and patients who receive radiation treatment to fields surrounding the heart.10,11,22,26 Although more research is needed to explore the potential benefits of lifestyle interventions specifically within survivor populations, the promotion of a healthy weight through a low-saturated-fat diet with ample amounts of fruits and vegetables and moderate levels of physical activity is recommended.14,15


Osteoporosis and osteopenia are prevalent conditions in the general population, especially among women. Despite epidemiologic findings that increased bone density and low fracture risk are associated with increased risk for breast cancer,27-35 clinical studies suggest that osteoporosis is still a prevalent health problem among survivors.36-39 Data of Twiss et al37 indicate that 80% of older breast cancer patients have t scores less than −1 and thus have clinically confirmed osteopenia at the time of their initial appointment. Other cancer populations, such as premenopausal breast and prostate cancer patients, may possess good skeletal integrity at the onset of their disease but are at risk of developing osteopenia, which may ensue with treatment-induced ovarian failure or androgen ablation.38,39


Previous studies indicate that functional status is lowest immediately after treatment and tends to improve over time; however, the presence of pain and co-occurring diseases may affect this relationship.40 In the older cancer survivor, regardless of duration after diagnosis, the presence of comorbidity rather than the history of cancer per se correlates with impaired functional status.41 Cancer survivors have an almost two-fold increase in having at least one functional limitation; however, in the presence of another comorbid condition, the odds ratio increases to 5.06 (95% CI, 4.47 to 5.72).42 These findings have been confirmed by other studies in diverse populations of cancer survivors.43-46 A cost analysis by Chirikos et al45 indicates that “the economic consequence of functional impairment exacts an enormous toll each year on cancer survivors, their families and the American economy at large.”


There are a variety of behavioral interventions that may mitigate elevated risk for the host of conditions for which the cancer survivor is especially vulnerable.1,2,47 However, because research on cancer survivorship is only just now receiving the attention it deserves, few studies have quantified longer-term physiologic outcomes of lifestyle change specifically within this population.48,49 According to the 2003 American Cancer Society Guide for Informed Choices, Nutrition and Physical Activity During and After Cancer Treatment, although no consensus exists to support “convincing evidence of benefit” as it relates to either disease-free or overall survival, current data do provide support for “probable” and “possible” benefit for several health behaviors, such as striving for a healthy weight, eating more fruits and vegetables and less saturated fat, and increasing physical activity.14 Although the focus of this article is on physical health, it is worth mentioning that some health behaviors, such as exercise are consistently associated with positive effects on psychological or emotional well-being (eg, mood states, self-esteem, and QOL) and reductions in fatigue.50-53 A recent study by Blanchard et al54 of 326 survivors of breast, prostate, and colorectal cancer suggests that survivors who exercise regularly, as well as those who practice more than one healthful behavior (ie, routine exercise, consumption of 5+ servings of fruits and vegetables per day, and tobacco abstinence), have significantly higher levels of health-related QOL than those who do not adhere to behavioral guidelines. Similarly, McBride et al55 found that psychological distress was lower among 988 breast and prostate cancer survivors who practiced healthful behaviors compared to those who did not.


A substantial number of reports suggest that cancer survivors spontaneously adopt lifestyle changes in hopes of achieving improved health. To date, published findings exist on > 20 studies that have explored persistent lifestyle practices among cancer survivors that extend beyond the year after diagnosis (Table 1).54,56-80 Although the preponderance of data suggest that the practice of healthful behaviors is notably higher among survivors, caution exists; given that such findings may be subject to bias (ie, survivors who do respond may be more likely to practice healthful behaviors).54 Findings of a recent prospective study by Satia et al81 on a population-based sample (N = 737), however, suggest that changes in lifestyle do accompany the cancer diagnosis; they observed significant increases in vegetable intake (P = .002) and physical activity (P < .001) among 278 colorectal cancer survivors from prediagnosis to 2-year follow-up, as compared with no change in age-, race-, and sex-matched controls.

Table 1
Post-Treatment Health-Behavior Practices Reported at Least 1 Year Beyond Diagnosis Among Adult Cancer Survivors


At the time of diagnosis, the incidence of smoking among cancer patients varies tremendously, with rates approaching 100% among those with tobacco-related cancers of the lung or esophagus2,60,65,66,71 and rates of < 10% among men and women diagnosed with non–tobacco-related cancers such as carcinoma of the prostate or breast.54,59 Quit rates vary accordingly and range from 46% to 96% among smokers with lung, head, or neck cancers, as compared with only 4% noted among smokers with breast cancer.59,60,61,65,66,72 Data from the National Health Interview Survey suggest that approximately 20% of cancer survivors continue to smoke. Although smoking prevalence among survivors is lower than that for those without a cancer history (24%), it is not appreciably lower. Also worrisome is the observation that the highest rates are among the youngest group of survivors (ages 18-44), > 40% of whom report current smoking.2 Alcohol abstinence ranges from 47% to 59% in those with head and neck cancers (in which the association between drinking and cancer is strong) to between 8% and 16% in breast and lung cancer survivors (in which the strength of association is either weaker and/or newly established).61,63,70 Current studies on alcohol and tobacco use among survivors are limited by their relatively short-term follow-up, especially given the history of recidivism for these addictive behaviors. To date, only Gritz et al65 have reported data on longer-term follow-up (up to 4 years postdiagnosis), showing durable quit rates of approximately 40% among smokers diagnosed with lung cancer.


Dietary modification is another prevalent behavior change noted after diagnosis. Consumption of a “healthier diet” is reported by 30% to 60% of survivors, with a majority indicating reduced intakes of meat and increased consumption of fruits and vegetables, although not all of these studies used standardized, validated instruments or subscales to ascertain dietary data. 58,59,64,68,69,70,73,74,76-78 A cross-sectional study by Tangney et al78 of 117 breast cancer survivors using a validated food-frequency questionnaire indicated mean Healthy Eating Index scores of 67.2 ± 13.2 within this population when compared with contemporaneous normative data existing on healthy women from the Continuing Survey of Food Intakes by Individuals (63.4 ± 13.3).82 The higher diet-quality scores described in this study were primarily a function of reported lower energy intakes (approximately 200 calories less per day) with concurrently higher fruit and lower meat consumption. Other studies suggest that 45% to 69% of survivors consume diets with < 30% of energy from fat and that 25% to 42% consume at least five servings of fruits and vegetables per day.54,59,74,77

Recent findings of a longitudinal study of 260 breast cancer survivors tracked over the course of 2 years suggests that although initial dietary changes such as reduced fat and increased fruit and vegetable intakes may occur postdiagnosis, significant recidivism in fat intake occurs over time and fruit and vegetable intake, although increased, still remains suboptimal in a majority of survivors (75.8%).83 Furthermore, a large proportion of successfully treated cancer survivors are overweight or obese, 11,14,15,18,20,22,48,74 with body weight increasing consistently and significantly over time,83 thus arguing for interventions aimed at energy restriction and/or increased physical activity.


Data regarding physical activity and cancer survivors are mixed, with some studies suggesting higher levels of physical activity,54,59,68,74,79 some suggesting no differences,57,67,75 and some suggesting less.58 Data from a study by Salminen et al76 indicate that 27% of survivors report more physical activity after diagnosis, whereas 10% report less after diagnosis. Interpretation of data is complicated further by recent shifts in guidelines. For example, a 2000 study by Demark-Wahnefried et al59 suggests that a majority of breast and prostate cancer survivors “routinely exercise.” However, this study was conducted at a time when the physical-activity guidelines were 20 minutes per day, 3 times per week, not the 30 minutes (American College of Sports Medicine) or the 60 minutes (Institute of Medicine) on most days per week currently recommended.84,85 Thus, it is doubtful whether a majority of survivors would be classified as “active” using these new criteria, although a recent study of breast, colon, and prostate cancer survivors by Blanchard et al54 suggests that 70% of survivors report exercising 30 minutes per day at least 5 days per week. As in the general population, cancer survivors frequently overestimate their level of physical activity; thus, these data are suspect.86,87 Regardless, it should be recognized that the impact of the media and the establishment of a role model may bring positive, sweeping change, as evidenced by the recent findings of Thorsen et al.79 In this study of testicular cancer survivors, an increased odds ratio of 1.32 (95% CI, 1.10 to 1.58) for physical activity was found, a result attributed to Lance Armstrong (testicular cancer survivor and seven-time winner of the Tour de France), because cycling accounted for much of the increased activity.


Although a substantial proportion of cancer survivors spontaneously initiate positive behavioral changes, many do not. Males and those who are less educated, over the age of 65, or who live in urban areas are less likely to either undertake healthful changes in behavior54,59,64,73 or maintain them.55,65,88 Data originating from the area of mammography screening clearly show that physicians are among the most powerful catalysts for promoting behavior change89,90 and therefore may be optimally positioned to deliver guidance regarding health promotion. Indeed in a recent randomized controlled trial (N = 450) conducted by Jones et al,91 breast cancer patients randomly assigned to an arm receiving an oncologist's recommendation to exercise reported a mean increase of 3.4 Metabolic Equivalents per week, compared with those not receiving a similar message (P = .011). Current reports, however, suggest that only approximately 20% of oncology care physicians provide assistance in this area—an unmet need that may be driven by competing treatment or health concerns, time constraints, or an unsurety regarding the delivery of appropriate health-behavior messages and their potential impact on health outcomes.54,59,92,93 Abbreviated reviews in areas of smoking cessation, diet, and exercise follow in an effort to inform oncologists of lifestyle interventions that have been conducted to date and their associated outcomes.


MacVicar and Winningham94 were the first to report results of a lifestyle intervention aimed at improving health among cancer survivors. Their study, which measured changes in functional capacity with an exercise program, was typical of many of the earlier behavioral studies that targeted cancer survivors (ie, studies on small samples, using quasi-experimental designs and using an amalgam of outcomes, including some that solely measured treatment-related issues such as nausea). During the ensuing years, the field has evolved, sample sizes of studies have increased, the rigor of experimental design has improved, and the breadth of studies has expanded. Although most of these behavioral interventions are focused on improving QOL and other psychosocial end points and are not included in this review, several are aimed specifically at improving physical health or functional outcomes. To date, published reports describe 20 exercise interventions,87,94-112 11 diet-related interventions (not including those limited to dietary supplements or single nutrients),113-123 two diet and exercise interventions,124,125 six behavioral-based smoking-cessation interventions,126-131 and one sun-protection intervention.132 Brief summaries of studies that used a randomized design are listed in Table 2.

Table 2
Randomized Intervention Trials Among Cancer Survivors Aimed at Improving Physical Function or Physical Health Outcomes Long Term


Smoking is well recognized for its causal association with lung and head and neck cancers, as well as CVD; however, less well known is its association with cancers of the cervix, bladder, and kidney.133 Thus, smoking cessation is of paramount importance for primary prevention and is essential also for preventing recurrence among those with tobacco-related carcinomas.134 Although one would expect that the cancer diagnosis may provide a “teachable moment,”6 Sanderson-Cox et al129 observed comparable uptake of a brief smoking-cessation intervention delivered by a nicotine-dependence counselor in both lung cancer and nonlung cancer patients (ie, 22% v 14% abstinence rates, respectively; no significant difference in adjusted analyses). Similarly, no observed differences were seen between quit rates of head and neck cancer patients who received standardized advice to quit versus those who received more intensive counseling by their surgeons.128 Schnoll et al130 also observed no significant differences in quit rates when they compared cancer patients who received standard of care to those who received a brief (<5-minute) smoking-cessation intervention from their physician. Taken together, these findings suggest that proven smoking-cessation interventions may be appropriate for use among cancer survivors; however, more work is needed to develop effective interventions for use in these high-risk and resistant populations.134


To date, there have been 11 reported dietary-intervention studies among cancer survivors. These have been divided equally across the following areas: (1) energy restriction115,116,119; (2) fat restriction113,114,118,123; and (3) a plant-based, low-fat diet.117,120,121,122 Dietary intake has been reported in seven of these studies, and findings suggest that interventions have been largely effective in promoting dietary change—a change that is confirmed in two of the three studies in which biomarkers of intake were collected (ie, serum carotenoids as a measure of fruit and vegetable intake).121,122 In eight studies, body weight was listed as an end point,113-119,123 and significant improvement in weight status was reported in all but one of these studies.119 Hormonal end points were measured in two of three studies that explored the effects of low-fat diet interventions, and findings suggest that estrogen profiles improved overall.113,123 Therefore, these dietary interventions seem successful, at least with respect to the end points considered. However, most dietary interventions to date have relied on intensive, in-person, individualized counseling sessions delivered by trained nutritionists and therefore are resource intensive. Kristal et al,118 Djuric et al,116 and Pierce et al121,122 have reported success in using less intensive interventions that are either delivered by trained volunteer staff, by commercial institutions (ie, Weight Watchers), or through telephone counseling, although trained nutritionists were still an important component of these interventions.

Combined approaches using individualized counseling, group classes, and telephone counseling have served as the delivery channels for two large, multisite, randomized controlled trials that should produce results regarding whether modifications in diet affect disease-free and/or overall survival. Published findings of the Women's Intervention Nutrition Study (a trial that will test the effect of a low-fat diet [< 15% of total calories] in approximately 2,500 postmenopausal breast cancer patients) are anticipated soon.135 Results of the Women's Healthy Eating and Living Study, a trial that will test the effect of more global dietary change (ie, daily intakes of five vegetable servings, 16 ounces of vegetable juice, three fruit servings, 15% to 20% energy from fat, and 30 g of dietary fiber) in 3,088 pre- and postmenopausal breast cancer patients are anticipated in 2006.121,122 Although preliminary findings suggest that these interventions have been effective in promoting biomarker-validated dietary change,121 the impact of dietary change on ultimate end points of disease progression and recurrence has yet to be determined. The results of both of these trials will be instrumental in filling the void that currently exists regarding the impact of dietary interventions on disease-free survival.

Although problems with anorexia and cachexia may continue among some groups of survivors such as those with head and neck cancers,14 for many survivors avoiding or controlling obesity is a far greater problem. 11,14,15,18,20,22,48,74 Here, multiple behavior interventions that use a comprehensive approach to energy balance and include both diet and exercise components may have the potential to be more effective than interventions relying on either component alone.136 In their evaluation of a diet and exercise intervention aimed at early-stage breast cancer patients, Goodwin et al124 found that aerobic exercise was the strongest predictor of weight loss. To date, findings of only two multiple behavior interventions among survivors have been reported, and both used quasi-experimental designs.124,125 There are, however, at least two studies that are currently in the field.7,8


Exercise-intervention trials have comprised the majority of the behavioral interventions conducted among cancer survivors to date. Many of these trials were undertaken to determine whether increased physical activity could relieve treatment-related nausea and fatigue or were aimed at improving QOL. Recent reviews by Courneya,50 Courneya and Friedenreich,51 Pinto and Maruyama,52 Schwartz,53 and the Agency for Healthcare Research and Quality136 find that exercise is consistently associated with improved QOL. The Agency for Healthcare Research and Quality review, as well as recent reviews by McTiernan49 and Galvao and Newton,137 suggest that exercise interventions have been effective also in improving physical functioning (ie, oxygen capacity, other fitness or strength measures, flexibility, and global health), anthropometric measures (ie, weight status, body fat, and waist and hip circumferences), and health-related biomarkers (ie, blood pressure, heart rate, hemoglobin concentration, and circulating hormonal levels). Increased engagement in social activities and less sleep disturbance have been reported also.94,95 A recent study by Fairey et al104 also suggests that exercise has a favorable effect on a subset of markers associated with metabolic syndrome such as insulin-like growth factor 1 and insulin-like growth factor-binding protein-3. Although it is clear that exercise is associated with many benefits for the cancer survivor, the impact of exercise on survival (whether overall or disease free) remains to be determined.49,136-138 Additionally, it still is unknown how soon after diagnosis exercise should be promoted.136 Although reviews suggest that early intervention has positive effects on QOL and several health outcomes, there is the potential, at least theoretically, for exercise to increase free-radical formation, reduce white blood cell counts, and interfere with treatment.49 Pre-existing conditions (eg, arthritis, chronic obstructive pulmonary disease) and adverse effects of treatment (eg, cardiac compromise secondary to anthracycline exposure) also may warrant caution in what types of exercise and how aggressively a survivor should pursue exercise after treatment. Thus, more research is necessary, as is prudent guidance for pursuing exercise in a moderate and stepped-dose approach, especially if undertaken during active treatment.49-53


As cancer joins the ranks of chronic disease, oncologists will increasingly find themselves at a juncture with their patients, as interests turn from acute care to managing long-term health. Cancer survivors thus present us with an exceptional opportunity to target primary, secondary, and tertiary prevention strategies capable of effecting beneficial outcomes at all three levels of prevention. A cancer survivor may simultaneously be a good candidate to receive (1) primary prevention messages such as reducing saturated fats in the diet and obesity management to prevent coronary heart disease and other potential comorbidities, (2) secondary prevention strategies such as screening for breast cancer in females previously treated for Hodgkin's Disease or regular screening for other secondary malignant neoplasms among those diagnosed and treated for cancer, and (3) tertiary prevention methods such as the early detection and management of late effects of cancer treatment such as heart disease after adriamycin chemotherapy. Such strategies may overlap; for example, the use of DEXRA or Zinecard in relation to adriamycin-based chemotherapy may have implications in both primary and tertiary prevention. Messages and strategies also must be tempered and are affected by multiple mediating or moderating factors such as age (current and at diagnosis/treatment), genetic risk profile (family history), concurrent comorbidities, and so on. Figure 1 presents a model of some of the more salient and complex associations between prevention strategies, attendant targets, and potential moderators or mediators. A recent review by Kattlove and Wynn139 also can help guide oncologists in providing quality continuing care for their patients—care that spans a broad spectrum of medical areas ranging from surveillance to genetic susceptibility. As noted, cancer survivors increasingly are looking to their oncology care providers for counsel and guidance with respect to lifestyle change that will improve their prospects of a healthier life and possibly a longer one as well.95,139 Although complete data regarding lifestyle change among cancer survivors have yet to be determined and there remains an unmet need for behavioral interventions with proven efficacy in various cancer populations,140 the oncologist nonetheless can make use of extant data to inform practice and also should be attentive to new developments in the field. Physician-based strategies also can be adopted from those that currently exist in primary care.141-148 Additionally, the development of partnerships with behavioral researchers, as well as allied health personnel, may be helpful in overcoming barriers of limited time, resources, and expertise in delivering effective lifestyle interventions.149 A resource list of organizations that provide sound information regarding lifestyle behaviors also is provided in Table 3 to facilitate this exchange. For decades the cancer diagnosis has been acknowledged as a life-changing event. It is time for oncology care providers not only to lead their patients away from disease but also to capitalize on the teachable moment that cancer provides and guide their patients to better health.

Fig 1
Model for preventive health among cancer survivors.
Table 3
Selected Listing of Resources to Inform Healthful Lifestyle Change


Supported by National Institutes of Health grant Nos. CA81191 (W.D.-W.), CA92468 (W.D.-W.), CA106919 (W.D.-W.), and The Susan G. Komen Foundation (W.D.-W. and N.M.A.), American Cancer Society (B.M.P.), and The Lance Armstrong Foundation (B.M.P.).

Parts of this article have been used to develop a chapter (coauthors: W.D.-W. and N.M.A.) within a planned volume entitled “Handbook of Behavioral Science and Cancer” to be published by the American Psychological Association later this year.

Authors' Disclosures of Potential Conflicts of Interest

The authors indicated no potential conflicts of interest.


1. Aziz N. Cancer survivorship research: Challenge and opportunity. J Nutr. 2002;132(suppl 2):3494S–3503S. [PubMed]
2. Aziz N, Rowland J. Trends and advances in cancer survivorship research: Challenge and opportunity. Semin Radiat Oncol. 2003;13:248–266. [PubMed]
3. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1875-2001, with a special feature regarding survival. Cancer. 2004;101:3–27. [PubMed]
4. Rowland J, Mariotto A, Aziz N, et al. Cancer survivorship—United States, 1971-2001. MMWR. 2004;53:526–529. [PubMed]
5. McBride CM, Emmons KM, Lipkus I. Understanding the potential of teachable moments: The case of smoking. Cessation Health Ed Res. 2003;18:156–170. [PubMed]
6. McBride CM, Ostroff JS. Teachable moments for promoting smoking cessation: The context of cancer care and survivorship. Cancer Control. 2003;10:325–333. [PubMed]
7. Demark-Wahnefried W, Clipp EC, McBride C, et al. Design of FRESH START: A randomized trial of exercise and diet among cancer survivors. Med Sci Sports Exerc. 2003;35:415–424. [PubMed]
8. Demark-Wahnefried W, Clipp EC, Morey M, et al. Leading the Way in Exercise and Diet (Project LEAD): Intervening to improve function among older breast and prostate cancer survivors. Control Clin Trials. 2003;24:206–223. [PubMed]
9. Day RW. Future need for more cancer research. J Am Diet Assoc. 1998;98:523. [PubMed]
10. Brown BW, Brauner C, Minnotte MC. Noncancer deaths in white adult cancer patients. J Natl Cancer Inst. 1993;85:979–997. [PubMed]
11. Ganz PA. Late effects of cancer and its treatment. Semin Oncol Nurs. 2001;17:241–248. [PubMed]
12. Meadows AT, Varricchio C, Crosson K, et al. Research issues in cancer survivorship: Report of a workshop sponsored by the Office of Cancer Survivorship, National Cancer Institute. Cancer Epidemiol Biomarkers Prev. 1998;7:1145–1151. [PubMed]
13. Travis LB. Therapy-associated solid tumors. Acta Oncol. 2002;41:323–333. [PubMed]
14. Brown JK, Byers T, Doyle C, et al. Nutrition and physical activity during and after cancer treatment: An American Cancer Society guide for informed choices. CA Cancer J Clin. 2003;53:268–291. [PubMed]
15. Rock CL, Demark-Wahnefried W. Nutrition and survival after the diagnosis of breast cancer: A review of the evidence. J Clin Oncol. 2002;20:3302–3316. [PMC free article] [PubMed]
16. Bergstrom A, Pisani P, Tenet V, et al. Overweight as an avoidable cause of cancer in Europe. Int J Cancer. 2001;91:421–430. Erratum: Int J Cancer 92:927, 2001. [PubMed]
17. World Health Organization . IARC Handbook of Cancer Prevention (ISSN 1027-5622) Vol. 6. IARC Press; Lyon, France: 2002.
18. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol. 2002;20:1128–1143. [PubMed]
19. Nuver J, Smit AJ, Postma A, et al. The metabolic syndrome in long-term cancer survivors, an important target for secondary measures. Cancer Treat Rev. 2002;28:195–214. [PubMed]
20. Freedland SJ, Aronson WJ, Kane CJ, et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: A report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol. 2004;22:446–453. [PubMed]
21. Argiles JM, Lopez-Soriano FJ. Insulin and cancer. Int J Oncol. 2001;18:683–687. [PubMed]
22. Bines J, Gradishar WJ. Primary care issues for the breast cancer survivor. Compr Ther. 1997;23:605–611. [PubMed]
23. Yoshikawa T, Noguchi Y, Doi C, et al. Insulin resistance in patients with cancer: Relationships with tumor site, tumor stage, body-weight loss, acute-phase response, and energy expenditure. Nutrition. 2001;17:590–593. [PubMed]
24. Balkau B, Kahn HS, Courbon D, et al. Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fatal cancer at some other sites: The Paris Prospective Study. Diabetes Care. 2001;24:843–849. [PubMed]
25. Lamont EB, Christakis NA, Lauderdale DS. Favorable cardiac risk among elderly breast carcinoma survivors. Cancer. 2003;98:2–10. [PubMed]
26. Hull MC, Morris CG, Pepine CJ, et al. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA. 2003;290:2831–2837. [PubMed]
27. Buist DS, LaCroix AZ, Barlow WE, et al. Bone mineral density and endogenous hormones and risk of breast cancer in postmenopausal women (United States) Cancer Causes Control. 2001;12:213–222. [PubMed]
28. Buist DS, LaCroix AZ, Barlow WE, et al. Bone mineral density and breast cancer risk in postmenopausal women. J Clin Epidemiol. 2001;54:417–422. [PubMed]
29. Cauley JA, Lucas FL, Kuller LH, et al. Bone mineral density and risk of breast cancer in older women: The study of osteoporotic fractures: Study of Osteoporotic Fractures Research Group. JAMA. 1996;276:1404–1408. [PubMed]
30. Lamont EB, Lauderdale DS. Low risk of hip fracture among elderly breast cancer survivors. Ann Epidemiol. 2003;13:698–703. [PubMed]
31. Lucas FL, Cauley JA, Stone RA, et al. Bone mineral density and risk of breast cancer: Differences by family history of breast cancer. Study of Osteoporotic Fractures Research Group. Am J Epidemiol. 1998;148:22–29. [PubMed]
32. Newcomb PA, Trentham-Dietz A, Egan KM, et al. Fracture history and risk of breast and endometrial cancer. Am J Epidemiol. 2001;153:1071–1078. [PubMed]
33. van der Klift M, de Laet CE, Coebergh JW, et al. Bone mineral density and the risk of breast cancer: The Rotterdam Study. Bone. 2003;32:211–216. [PubMed]
34. Zhang Y, Kiel DP, Kreger BE, et al. Bone mass and the risk of breast cancer among post-menopausal women. N Engl J Med. 1997;336:611–617. [PubMed]
35. Zmuda JM, Cauley JA, Ljung BM, et al. Bone mass and breast cancer risk in older women: Differences by stage at diagnosis. J Natl Cancer Inst. 2001;93:930–936. [PubMed]
36. Schultz PN, Beck ML, Stava C, et al. Health profiles in 5836 long-term cancer survivors. Int J Cancer. 2003;104:488–495. [PubMed]
37. Twiss JJ, Waltman N, Ott CD, et al. Bone mineral density in postmenopausal breast cancer survivors. J Am Acad Nurse Pract. 2001;13:276–284. [PubMed]
38. Ramaswamy B, Shapiro CL. Osteopenia and osteoporosis in women with breast cancer. Semin Oncol. 2003;30:763–775. [PubMed]
39. Diamond TH, Higano CS, Smith MR, et al. Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: Recommendations for diagnosis and therapies. Cancer. 2004;100:892–899. [PubMed]
40. Ko CY, Maggard M, Livingston EH. Evaluating health utility in patients with melanoma, breast cancer, colon cancer, and lung cancer: A nationwide, population-based assessment. J Surg Res. 2003;114:1–5. [PubMed]
41. Garman KS, Pieper CF, Seo P, et al. Function in elderly cancer survivors depends on comorbidities. J Gerontol A Biol Sci Med Sci. 2003;58:M1119–M1124. [PubMed]
42. Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: Age, health and disability. J Gerontol A Biol Sci Med Sci. 2003;58:82–91. [PubMed]
43. Ashing-Giwa K, Ganz PA, Petersen L. Quality of life of African-American and white long term breast carcinoma survivors. Cancer. 1999;85:418–426. Erratum: Cancer 86:732-733, 1999. [PubMed]
44. Baker F, Haffer S, Denniston M. Health-related quality of life of cancer and noncancer patients in Medicare managed care. Cancer. 2003;97:674–681. [PubMed]
45. Chirikos TN, Russell-Jacobs A, Jacobsen PB. Functional impairment and the economic consequences of female breast cancer. Women Health. 2002;36:1–20. [PubMed]
46. Mandelblatt JS, Edge SB, Meropol NJ, et al. Predictors of long-term outcomes in older breast cancer survivors: Perceptions versus patterns of care. J Clin Oncol. 2003;21:255–263. [PubMed]
47. Pinto B, Eakin E, Maruyama N. Health behavior changes after a cancer diagnosis: What do we know and where do we go from here? Ann Behav Med. 2000;22:38–52. [PubMed]
48. Chlebowski RT. The American Cancer Society guide for nutrition and physical activity for cancer survivors: A call to action for clinical investigators. CA Cancer J Clin. 2003;53:266–267. [PubMed]
49. McTiernan A. Physical activity after cancer: Physiologic outcomes. Cancer Invest. 2004;22:68–81. [PubMed]
50. Courneya K. Exercise in cancer survivors: An overview of research. Med Sci Sports Exerc. 2003;35:1846–1852. [PubMed]
51. Courneya K, Friedenreich C. Physical exercise and quality of life following cancer diagnosis: A literature review. Ann Behav Med. 1999;21:171–179. [PubMed]
52. Pinto BM, Maruyama NC. Exercise in the rehabilitation of breast cancer survivors. Psychooncology. 1999;8:191–206. [PubMed]
53. Schwartz AL. Physical activity after a cancer diagnosis: Psychosocial outcomes. Cancer Invest. 2004;22:82–92. [PubMed]
54. Blanchard CM, Stein KD, Baker F, et al. Association between current lifestyle behaviors and health-related quality of life in breast, colorectal and prostate cancer survivors. Psychol Health. 2004;19:1–13.
55. McBride CM, Clipp E, Peterson B, et al. Psychological impact of diagnosis and risk reduction among cancer survivors. Psychooncology. 2000;9:418–427. [PubMed]
56. Allison P. Factors associated with smoking and alcohol consumption following treatment for head and neck cancer. Oral Oncol. 2001;37:513–520. [PubMed]
57. Blanchard CM, Baker F, Denniston MM, et al. Is absolute amount or change in exercise more associated with quality of life in adult cancer survivors? Prev Med. 2003;37:389–395. [PubMed]
58. Blanchard C, Denniston M, Baker F, et al. Do adults change their lifestyle behaviors after a cancer diagnosis? Am J Health Behav. 2003;27:246–256. [PubMed]
59. Demark-Wahnefried W, Peterson B, McBride C, et al. Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer. 2000;88:674–684. [PubMed]
60. Dresler CM, Bailey M, Roper CR, et al. Smoking cessation and lung cancer resection. Chest. 1996;110:1199–1202. [PubMed]
61. Duffy S, Terrell J, Valenstein M, et al. Effect of smoking, alcohol, and depression on the quality of life of head and neck cancer patients. Gen Hosp Psychiatry. 2002;24:140–147. [PubMed]
62. Earle C, Burstein H, Winer E, et al. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol. 2003;21:1447–1452. [PubMed]
63. Evangelista L, Sarna L, Brecht M, et al. Health perceptions and risk behaviors of lung cancer survivors. Heart Lung. 2003;32:131–139. [PubMed]
64. Ganz PA, Desmond KA, Leedham B, et al. Quality of life in long-term, disease-free survivors of breast cancer: A follow-up study. J Natl Cancer Inst. 2002;94:39–49. Erratum: J Natl Cancer Inst 94:463, 2002. [PubMed]
65. Gritz E, Nisenbaum R, Elashoff R, et al. Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. Cancer Causes Control. 1991;2:105–112. [PubMed]
66. Gritz E, Schacherer C, Koehly L, et al. Smoking withdrawal and relapse in head and neck cancer patients. Head Neck. 1999;21:420–427. [PubMed]
67. Gross G, Ott C, Lindsey A, et al. Post-menopausal breast cancer survivors at risk for osteoporosis: Physical activity, vigor, and vitality. Oncol Nurs Forum. 2002;29:1295–1300. [PubMed]
68. Hounshell J, Tomori C, Newlin R, et al. Changes in finances, insurance, employment, and lifestyle among persons diagnosed with hairy cell leukemia. Oncologist. 2001;6:435–444. [PubMed]
69. Maskarinec G, Murphy S, Shumay D, et al. Dietary changes among cancer survivors. Eur J Cancer Care. 2001;10:12–20. [PubMed]
70. Maunsell E, Drolet M, Brisson J, et al. Dietary change after breast cancer: Extent, predictors, and relation with psychological distress. J Clin Oncol. 2002;20:1017–1025. [PubMed]
71. Ostroff JS, Jacobsen PB, Moadel AB, et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 1995;75:569–576. [PubMed]
72. Ostroff J, Garland J, Moadel A, et al. Cigarette smoking patterns in patients after treatment of bladder cancer. J Cancer Educ. 2000;15:86–90. [PubMed]
73. Patterson RE, Neuhouser ML, Hedderson MM, et al. Changes in diet, physical activity, and supplement use among adults diagnosed with cancer. J Am Diet Assoc. 2003;103:323–328. [PubMed]
74. Pinto B, Maruyama N, Clark M, et al. Motivation to modify lifestyle risk behaviors in women treated for breast cancer. Mayo Clin Proc. 2002;77:122–129. [PubMed]
75. Pinto B, Trunzo J, Reiss P, et al. Exercise participation after diagnosis of breast cancer: Trends and effects on mood and quality of life. Psychooncology. 2002;11:389–400. [PubMed]
76. Salminen E, Heikkila S, Poussa T, et al. Female patients tend to alter their diet following the diagnosis of rheumatoid arthritis and breast cancer. Prev Med. 2002;34:529–535. [PubMed]
77. Steward D, Wiener F, Gleich L, et al. Dietary antioxidant intake in patients at risk for second primary cancer. Laryngoscope. 2003;113:1487–1493. [PubMed]
78. Tangney C, Young J, Murtaugh M, et al. Self-reported dietary habits, overall dietary quality and symptomatology of breast cancer survivors: A cross-sectional examination. Breast Cancer Res Treat. 2002;71:113–123. [PubMed]
79. Thorsen L, Nystad W, Dahl O, et al. The level of physical activity in long-term survivors of testicular cancer. Eur J Cancer. 2003;39:1216–1221. [PubMed]
80. Vander Ark W, DiNardo L, Oliver D. Factors affecting smoking cessation in patients with head and neck cancer. Laryngoscope. 1997;107:888–892. [PubMed]
81. Satia JA, Campbell MK, Galanko JA, et al. Longitudinal changes in lifestyle behaviors and health status in colon cancer survivors. Cancer Epidemiol Biomarkers Prev. 2004;13:1022–1031. [PubMed]
82. US Department of Agriculture . Agricultural Research Service 1994-1996 Continuing Survey of Food Intakes by Individuals and 1994-1996 Diet and Health Knowledge Survey. Department of Agriculture; Beltsville, MD: 1998. CD-ROM.
83. Wayne SJ, Lopez ST, Butler LM, et al. Changes in dietary intake after diagnosis of breast cancer. J Am Diet Assoc. 2004;104:1561–1568. [PubMed]
84. American College of Sports Medicine Guidelines, 3/24/04 update. Available at:
85. Institute of Medicine Fulfilling the promise of cancer and prevention and early detection.
86. Irwin ML, Ainsworth BE. Physical activity interventions following cancer diagnosis: Methodologic challenges to delivery and assessment. Cancer Invest. 2004;22:30–50. [PubMed]
87. Snyder DC, Sloane R, Lobach D, et al. Agreement between a brief mailed screener and an in-depth telephone survey: Observations from the Fresh Start study. J Am Diet Assoc. 2004;104:1593–1596. [PubMed]
88. Pinto BM, Frierson GM, Robin C, et al. Home-based physical activity intervention for breast cancer patients. J Clin Oncol. 2005;23:3577–3587. [PubMed]
89. Mandelblatt J, Kanetsky PA. Effectiveness of interventions to enhance physician screening for breast cancer. J Fam Pract. 1995;40:162–171. [PubMed]
90. Rimer BK. Improving the use of cancer screening for older women. Cancer. 1993;72(suppl 3):1084–1087. [PubMed]
91. Jones LW, Courneya KS, Fairey AS, et al. Effects of an oncologist's recommendation to exercise on self-reported exercise behavior in newly diagnosed breast cancer survivors: A single-blind, randomized controlled trial. Ann Behav Med. 2004;28:105–113. [PubMed]
92. Yarnall KS, Pollak KI, Ostbye T, et al. Primary care: Is there enough time for prevention? Am J Public Health. 2003;93:635–641. [PubMed]
93. Ahuja R, Weibel SB, Leone FT. Lung cancer: The oncologist's role in smoking cessation. Semin Oncol. 2003;30:94–103. [PubMed]
94. MacVicar M, Winningham M. Promoting the functional capacity of cancer patients. Cancer Bull. 1986;38:235–239.
95. Berglund G, Bolund C, Gustafsson U, et al. Starting Again—A comparison study of a group rehabilitation program for cancer patients. Acta Oncol. 1993;32:15–21. [PubMed]
96. Berglund G, Bolund C, Gustafson U. Randomized study of a rehabilitation program for cancer patients: The “Starting Again” group. Psychooncology. 1994;3:109–120.
97. Burnham T, Wilcox A. Effects of exercise on physiological and psychological variables in cancer survivors. Med Sci Sports Exerc. 2002;34:1863–1867. [PubMed]
98. Courneya K, Friedenreich C, Sela R, et al. The group psychotherapy and home-based physical exercise (group-hope) trial in cancer survivors: Physical fitness and quality of life outcomes. Psychooncology. 2003;12:357–374. [PubMed]
99. Courneya K, Mackey J, Bell G, et al. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: Cardiopulmonary and quality of life outcomes. J Clin Oncol. 2003;21:1660–1668. [PubMed]
100. Dimeo F, Bertz H, Finke J. An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation. Bone Marrow Transplant. 1996;18:1157–1160. [PubMed]
101. Dimeo F, Fetcher S, Lange W, et al. Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy. Blood. 1997;90:3390–3394. [PubMed]
102. Dimeo F, Rumberger B, Keul J. Aerobic exercise as therapy for cancer fatigue. Med Sci Sports Exerc. 1998;30:475–478. [PubMed]
103. Dimeo F, Tilman M, Bertz H, et al. Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation. Cancer. 1997;79:1717–1722. [PubMed]
104. Fairey AS, Courneya KS, Field CJ, et al. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: A randomized controlled trial. Cancer Epidemiol Biomarkers Prev. 2003;12:721–727. [PubMed]
105. Kolden G, Strauman T, Ward A, et al. A pilot study of group exercise training (GET) for women with primary breast cancer: Feasibility and health benefits. Psychooncology. 2002;11:447–456. [PubMed]
106. MacVicar M, Winningham M, Nickel J. Effects of aerobic interval training on cancer patients' functional capacity. Nurs Res. 1989;38:348–351. [PubMed]
107. McKenzie DC, Kalda AL. Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: A pilot study. J Clin Oncol. 2003;21:463–466. [PubMed]
108. McTiernan A, Ulrich C, Kumai C, et al. Anthropometric and hormone effects of an eight-week exercise-diet intervention in breast cancer patients: Results of a pilot study. Cancer Epidemiol Biomarkers Prev. 1998;7:477–481. [PubMed]
109. Peters C, Lotzerich H, Niemeier B, et al. Influence of a moderate exercise training on natural killer cytotoxicity and personality traits in cancer patients. Anticancer Res. 1994;14:1033–1036. [PubMed]
110. Segal R, Evans W, Johnson D, et al. Structured exercise improves physical functioning in women with stages I and II breast cancer: Results of a randomized controlled trial. J Clin Oncol. 2001;19:657–665. [PubMed]
111. Segal R, Reid R, Courneya K, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol. 2003;21:1653–1659. [PubMed]
112. Winningham ML, MacVicar MG, Bondoc M, et al. Effect of aerobic exercise on body weight and composition in patients with breast cancer on adjuvant chemotherapy. Oncol Nurs Forum. 1989;16:683–689. [PubMed]
113. Boyar AP, Rose DP, Loughridge JR, et al. Response to a diet low in total fat in women with postmenopausal breast cancer: A pilot study. Nutr Cancer. 1988;11:93–99. [PubMed]
114. Chlebowski RT, Rose D, Buzzard M, et al. Adjuvant dietary fat intake reduction in postmenopausal breast cancer patient management: The Women's Intervention Nutrition Study (WINS) Breast Cancer Res Treat. 1991;20:73–84. [PubMed]
115. deWaard F, Ramlau R, Mulders Y, et al. A feasibility study on weight reduction in obese postmenopausal breast cancer patients. Eur J Cancer Prev. 1993;2:233–238. [PubMed]
116. Djuric Z, DiLaura N, Jenkins I, et al. Combining weight-loss counseling with the Weight Watchers plan for obese breast cancer survivors. Obesity Res. 2002;10:657–665. [PubMed]
117. Hebert JR, Ebbeling CB, Olendzki BC, et al. Change in women's diet and body mass following intensive intervention for early-stage breast cancer. J Am Diet Assoc. 2001;101:421–431. [PubMed]
118. Kristal A, Shattuck A, Bowen D, et al. Feasibility of using volunteer research staff to deliver and evaluate a low-fat dietary intervention: The American Cancer Society Breast Cancer Dietary Intervention Project. Cancer Epidemiol Biomarkers Prev. 1997;6:459–467. [PubMed]
119. Loprinzi CL, Athmann LM, Kardinal CG, et al. Randomized trial of dietician counseling to try to prevent weight gain associated with breast cancer adjuvant chemotherapy. Oncology. 1996;53:228–232. [PubMed]
120. Nordevang E, Callmer E, Marmur A, et al. Dietary intervention in breast cancer patients: Effects on food choice. Eur J Clin Nutr. 1992;46:387–396. [PubMed]
121. Pierce J, Faerber S, Wright F, et al. Feasibility of a randomized trial of a high-vegetable diet to prevent breast cancer recurrence. Nutr Cancer. 1997;28:282–288. [PubMed]
122. Pierce J, Newman VA, Flatt SW, et al. Telephone counseling intervention increases intakes of micronutrient- and phytochemical-rich vegetables, fruit and fiber in breast cancer survivors. J Nutr. 2004;134:452–458. [PubMed]
123. Rose DP, Connolly JM, Chlebowski RT, et al. The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Res Treat. 1993;27:253–262. [PubMed]
124. Goodwin P, Esplen MJ, Butler K, et al. Multidisciplinary weight management in locoregional breast cancer: Results of a phase II study. Breast Cancer Res Treat. 1998;48:53–64. [PubMed]
125. Demark-Wahnefried W, Kenyon A, Eberle P, et al. Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: Results of a feasibility study. Clin Exerc Physiol. 2002;4:44–49. [PMC free article] [PubMed]
126. Browning KK, Ahijevych KL, Ross P, Jr, et al. Implementing the Agency for Health Care Policy and Research's Smoking Cessation Guideline in a lung cancer surgery clinic. Oncol Nurs Forum. 2000;27:1248–1254. [PubMed]
127. Griebel B, Wewers ME, Baker CA. The effectiveness of a nurse-managed minimal smoking-cessation intervention among hospitalized patients with cancer. Oncol Nurs Forum. 1998;25:897–902. [PubMed]
128. Gritz E, Carr C, Rapkin D. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1993;2:261–270. [PubMed]
129. Sanderson-Cox L, Patten C, Ebbert J, et al. Tobacco use outcomes among patients with lung cancer treated for nicotine dependence. J Clin Oncol. 2002;20:3461–3469. [PubMed]
130. Schnoll R, Zhang B, Rue M, et al. Brief physician-initiated quit-smoking strategies for clinical oncology settings: A trial coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol. 2003;21:355–365. [PubMed]
131. Stanislaw AE, Wewers ME. A smoking cessation intervention with hospitalized surgical cancer patients: A pilot study. Cancer Nurs. 1994;17:81–86. [PubMed]
132. Robinson J, Rademaker A. Skin cancer risk and sun protection learning by helpers of patients with non-melanoma skin cancer. Prev Med. 1995;24:333–341. [PubMed]
133. American Cancer Society Cancer prevention and early detection 2004. 7/2004 update,
134. Sanderson L, Aftricano NL, Tercyak KP, et al. Nicotine dependence treatment for patients with cancer. Review and recommendations. Cancer. 2003;98:632–644. Erratum: Cancer 98:1104, 2003. [PubMed]
135. Wynder EL, Cohen LA, Muscat JE, et al. Breast cancer: Weighing the evidence for a promoting role of dietary fat. J Natl Cancer Inst. 1997;89:766–775. [PubMed]
136. Agency for Healthcare Research and Quality . Effectiveness of Behavioral Interventions to Modify Physical Activity Behaviors in General Populations and Cancer Patients and Survivors. US Department of Health and Human Services (AHRQ publication 04-E027-2); Rockville, MD: 2004. pp. 107–111.
137. Galvao DA, Newton RU. Review of exercise intervention studies in cancer patients. J Clin Oncol. 2005;23:899–909. [PubMed]
138. Kuhn KG, Boesen E, Ross L, et al. Evaluation and outcome of behavioral change in the rehabilitation of cancer patients: A review. Eur J Cancer. 2005;41:216–224. [PubMed]
139. Kattlove H, Winn RJ. Ongoing care of patients after primary treatment for their cancer. CA Cancer J Clin. 2003;53:172–196. Erratum: CA Cancer J Clin 53:315, 2003. [PubMed]
140. Robison LL. Cancer survivorship: Unique opportunities for research. Cancer Epidemiol Biomarkers Prev. 2004;13:1093. [PubMed]
141. Goldstein MG, DePue J, Kazura A, et al. Models for provider-patient interaction: Applications to health behavior change. In: Shumaker SA, Schron E, Ockene J, et al., editors. Handbook of Health Behavior Change. ed 2 Springer; New York, NY: 1998. pp. 85–113.
142. Goldstein MG, Pinto BM, Marcus BH, et al. Physician-based physical activity counseling for middle-aged and older adults: A randomized trial. Ann Behav Med. 1999;21:40–47. [PubMed]
143. Goldstein MG, Whitlock EP, DePue J. Multiple behavioral risk factor interventions in primary care: Summary of research evidence. Am J Prev Med. 2004;27(2 suppl):61–79. [PubMed]
144. Lawlor DA, Hanratty B. The effect of physical activity advice given in routine primary care consultations: A systematic review. J Public Health Med. 2001;23:219–226. [PubMed]
145. Ockene JK, Zapka JG. Provider education to promote implementation of clinical practice guidelines. Chest. 2000;118(2 suppl):33S–39S. [PubMed]
146. Pinto BM, Goldstein MG, Marcus BH. Activity counseling by primary care physicians. Prev Med. 1998;27:506–513. [PubMed]
147. US Preventive Services Task Force Behavioral counseling in primary care to promote physical activity: Recommendation and rationale. Ann Intern Med. 2002;137:205–207. [PubMed]
148. Writing Group for the Activity Counseling Trial Research Group Effects of physical activity counseling in primary care: the Activity Counseling Trial: A randomized controlled trial. JAMA. 2001;286:677–687. [PubMed]
149. Trask PC, Schwartz SM, Deaner SL, et al. Behavioral medicine: The challenge of integrating psychological and behavioral approaches into primary care. Eff Clin Pract. 2002;5:75–83. [PubMed]